The Insight Series: AI & Digital Health
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery.…
Diagnostics
Learn more about our Diagnostics work.
AdvaMed® Announces Opening Nominations for its 2026 Lifetime Achievement, Dx Lifetime of Leadership & Service, and theAdvaMed® Imaging Röntgen Awards
WASHINGTON—AdvaMed® announced today that nominations for its 2025 Lifetime Achievement Award as well as the AdvaMedDx Lifetime of Leadership & Service Award and theAdvaMed® Imaging Röntgen Award are open through April 10. All three of these…
Perimeter Medical Imaging AI’s ‘Claire’ Becomes First FDA-approved AI-Enabled Imaging Device for Breast Cancer Surgery
TORONTO and DALLAS, March 3, 2026 /PRNewswire/ – Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (“Perimeter” or the “Company”), a commercial-stage medical technology company, announced today that it has received U.S.…
Heart Month: Why Sleep Apnea Belongs at the Center of Cardiovascular Care
February is American Heart Month—a time to spotlight cardiovascular disease and highlight innovations that can improve patient outcomes. For the medtech community, it’s an opportunity to address persistent gaps in…
AdvaMedDx Welcomes Reintroduction of the PASTEUR Act
WASHINGTON—AdvaMedDx, theAdvaMed® division representing the leading manufacturers of in vitro diagnostic tests, welcomed the reintroduction in the U.S. House of Representatives of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act by Reps. Earl L. “Buddy” Carter (R-Ga.),…
AdvaMed® Announces Melissa Torres as New Executive Vice President of Technology and Regulatory Affairs
WASHINGTON—AdvaMed, the MedTech Association®, today announced Melissa Torres is the new Executive Vice President of Technology and Regulatory Affairs. Torres succeeds Janet Trunzo, who retired after 30 distinguished, productive years withAdvaMed®.
AdvaMed® Receives RAPS Accreditation for Medical Device Submissions Workshop Series (February 2026 in Washington, D.C.)
WASHINGTON, D.C.—AdvaMed, the world’s largest trade association representing medical technology innovators, announced that its Medical Device Submissions Workshop Series (February 23-27 in Washington, D.C.) has been officially approved for RAC…
The Insight Series: AI & Digital Health
AdvaMed® Digital Health Tech division member companies include world leaders in developing AI-enabled solutions to improve health and care, from diagnosis to treatment, clinical decision support, and wearables to wellness.…
Honoring Janet E. Trunzo: A Legacy That Shaped Modern Medtech Regulation
After 30 years atAdvaMed®, Janet E. Trunzo, Senior Advisor to the President and Senior Executive Vice President of Technology and Regulatory Affairs, will retire on January 31, 2026. Her tenure…
Why the Health Tech Investment Act Matters: Peter Weems Breaks Down What This Means for Patients
In a new video developed in partnership with Patients Rising, AdvaMed’s Peter Weems, Vice President of Imaging Government Affairs and Policy Strategy, explains why the Health Tech Investment Act is critical to expanding patient…